Mastering Cardiology · Cheat sheet
ACLS decision points
Draft — pending owner review
Decision points
- Rhythm check: is it shockable?
Cardiac arrest: VF, pulseless VT, asystole and PEA: Yes: VF or pulseless VT No: asystole or PEA - Is the bradyarrhythmia causing any of these? (Hypotension; Acutely altered mental status; Signs of shock; Ischemic chest discomfort; Acute heart failure)
Bradycardia with a pulse: No Yes - Is the tachyarrhythmia causing any of these? (Hypotension; Acutely altered mental status; Signs of shock; Ischemic chest discomfort; Acute heart failure)
Tachycardia with a pulse: Yes: unstable No: stable - Is the QRS wide (≥ 120 ms)?
Tachycardia with a pulse: Wide Narrow - Is there an organized QRS to synchronize to?
Electrical therapy: cardioversion, defibrillation and pacing: No: VF, pulseless VT, polymorphic VT Yes: unstable SVT, AF, flutter, monomorphic VT with a pulse - Symptomatic bradycardia not responding to atropine?
Electrical therapy: cardioversion, defibrillation and pacing: Yes No - 12-lead ECG: STEMI, cardiogenic shock or a likely cardiac cause?
Post–cardiac arrest care: STEMI, shock or high suspicion No - Is the patient following commands (off sedation)?
Post–cardiac arrest care: No, or cannot assess Yes - What does the 12-lead show?
Acute coronary syndromes: ST elevation (STEMI) or an occlusion equivalent ST depression or dynamic T-wave inversion Normal or nondiagnostic - Can primary PCI happen within 120 minutes of first medical contact?
Acute coronary syndromes: Yes No, and onset within 12 hours - Does imaging show hemorrhage?
Suspected stroke: Yes: hemorrhage No hemorrhage - Within 4.5 hours of last known well, and eligible?
Suspected stroke: Yes No, or ineligible - Large vessel occlusion on CT angiography?
Suspected stroke: Yes No - Is the person breathing normally?
Opioid-associated emergency: Yes No - Is there a definite pulse (check for no more than 10 seconds)?
Opioid-associated emergency: Yes: respiratory arrest No: cardiac arrest - Breathing restored?
Opioid-associated emergency: Yes No - ROSC within the first few minutes?
Cardiac arrest in pregnancy: Yes No - PEA or asystole: which cause fits the clues?
PEA: the H's and T's: Hypovolemia Hypoxia Hydrogen ion (acidosis) Hypo- or hyperkalemia Hypothermia Tension pneumothorax Tamponade (cardiac) Toxins Thrombosis (pulmonary) Thrombosis (coronary) I have been through the list - Rhythm check: is it shockable?
Pediatric cardiac arrest (PALS): Shockable: VF or pulseless VT Not shockable: asystole or PEA - After 2 minutes: rhythm check
Pediatric cardiac arrest (PALS): Still shockable ROSC Asystole or PEA - Rhythm check
Pediatric cardiac arrest (PALS): Still shockable ROSC Asystole or PEA - After 2 minutes: rhythm check
Pediatric cardiac arrest (PALS): Now shockable Still asystole or PEA ROSC - Cardiopulmonary compromise? (hypotension, acutely altered mental status, signs of shock)
Pediatric bradycardia with a pulse (PALS): No Yes - Despite oxygenation and ventilation: heart rate below 60/min with poor perfusion?
Pediatric bradycardia with a pulse (PALS): Yes No: rate above 60 - Bradycardia persists?
Pediatric bradycardia with a pulse (PALS): Yes No: rate and perfusion improved - Is the QRS narrow (0.09 s or less) or wide (more than 0.09 s)?
Pediatric tachycardia with a pulse (PALS): Narrow Wide - Probable sinus tachycardia or SVT?
Pediatric tachycardia with a pulse (PALS): Probable sinus tachycardia Probable SVT - Cardiopulmonary compromise?
Pediatric tachycardia with a pulse (PALS): No Yes - Possible VT: cardiopulmonary compromise?
Pediatric tachycardia with a pulse (PALS): Yes No - Reassess after each bolus
Pediatric septic shock (PALS): Improving, no overload Overload signs: crackles, enlarging liver Still in shock after 40–60 mL/kg - Still in shock on vasoactive infusions?
Pediatric septic shock (PALS): Yes No
Reversible causes
- H's
- Hypovolemia, hypoxia, hydrogen ion (acidosis), hypo-/hyperkalemia, hypothermia
- T's
- Tension pneumothorax, tamponade, toxins, thrombosis (pulmonary), thrombosis (coronary)
Energies and doses
Verify against current local protocol. The full 2025 guideline text could not be opened when this page was drafted; the 2025 changes listed were confirmed from summaries of AHA's published 2025 algorithms and highlights. Drug doses are the 2020 algorithm doses, which those 2025 algorithms keep.
| Defibrillation, biphasic | Manufacturer recommendation (for example, initial dose of 120–200 J); if unknown, use the maximum available. Second and later doses should be equivalent; higher doses may be considered.AHA 2020 adult algorithm |
|---|---|
| Defibrillation, monophasic | 360 JAHA 2020 adult algorithm |
| Epinephrine IV/IO | 1 mg every 3–5 minutesAHA 2020 adult algorithm |
| Amiodarone IV/IO | First dose 300 mg bolus; second dose 150 mgAHA 2020 adult algorithm |
| Lidocaine IV/IO (alternative to amiodarone) | First dose 1–1.5 mg/kg; second dose 0.5–0.75 mg/kgAHA 2020 adult algorithm |
| Atropine IV | First dose 1 mg bolus; repeat every 3–5 minutes; maximum 3 mgAHA 2020 adult algorithm |
| Dopamine IV infusion | 5–20 mcg/kg per minute; titrate to patient response; taper slowlyAHA 2020 adult algorithm |
| Epinephrine IV infusion | 2–10 mcg per minute; titrate to patient responseAHA 2020 adult algorithm |
| Synchronized cardioversion | Refer to your specific device's recommended energy level to maximize first-shock success.AHA 2020 adult algorithm |
| Synchronized cardioversion of AF (2025 change) | Initial energy of at least 200 J with a biphasic defibrillatorAHA 2025 Guidelines, Part 9: Adult Advanced Life Support (as reported in the 2025 highlights) |
| Adenosine IV | First dose 6 mg rapid IV push, followed by a normal saline flush; second dose 12 mg if requiredAHA 2020 adult algorithm |
| Procainamide IV (stable wide-QRS) | 20–50 mg/min until the arrhythmia is suppressed, hypotension ensues, QRS duration increases > 50% or a maximum of 17 mg/kg is given; maintenance 1–4 mg/min; avoid if prolonged QT or heart failureAHA 2020 adult algorithm |
| Amiodarone IV (stable wide-QRS) | First dose 150 mg over 10 minutes; repeat as needed if VT recurs; follow with a maintenance infusion of 1 mg/min for the first 6 hoursAHA 2020 adult algorithm |
| Sotalol IV (stable wide-QRS) | 100 mg (1.5 mg/kg) over 5 minutes; avoid if prolonged QT. No longer listed in the 2025 algorithm.AHA 2020 adult algorithm; removed from the AHA 2025 algorithm |
| Oxygen | Titrate FiO₂ to SpO₂ 90–98%AHA 2025 post-cardiac arrest care algorithm |
| Ventilation | PaCO₂ 35–45 mm HgAHA 2025 post-cardiac arrest care algorithm |
| Blood pressure | MAP 65 mm Hg or more (fluids, norepinephrine or epinephrine infusion)AHA 2025 post-cardiac arrest care algorithm |
| Temperature control | Goal 32–37.5 °C for at least 36 hours if not following commands; prevent feverAHA 2025 Guidelines, Part 11 (duration as reported in summaries; confirm) |
| Aspirin | 162–325 mg chewed (non-enteric-coated)ACC/AHA 2025 acute coronary syndromes guideline; AHA ACLS teaching |
| Nitroglycerin | 0.4 mg sublingual every 5 minutes, up to 3 doses, if systolic BP ≥ 90ACC/AHA 2025 acute coronary syndromes guideline; AHA ACLS teaching |
| Oxygen | Only if SpO₂ < 90%ACC/AHA 2025 acute coronary syndromes guideline |
| Alteplase | 0.9 mg/kg (max 90 mg): 10% as a bolus over 1 minute, the rest over 60 minutesAHA/ASA stroke guidelines (2019, 2026) as taught in AHA 2020 ACLS |
| Tenecteplase | 0.25 mg/kg (max 25 mg) single bolusAHA/ASA 2026 stroke guideline (as reported); not in AHA 2020 ACLS |
| Blood pressure before thrombolysis | Below 185/110 mm Hg; then at or below 180/105 for 24 hoursAHA/ASA stroke guidelines as taught in AHA 2020 ACLS |
| Naloxone intranasal | 4 mg, repeat every 2–3 minutesAHA 2020 opioid-associated emergency algorithms; naloxone endorsed in the AHA 2025 guidelines |
| Naloxone IM/IV | 0.4 mg, titrated, repeat every 2–3 minutesAHA 2020 opioid-associated emergency algorithms; naloxone endorsed in the AHA 2025 guidelines |
| Defibrillation and drugs | Standard adult energies and dosesAHA 2025 cardiac arrest in pregnancy algorithm |
| Resuscitative hysterotomy | If no ROSC: aim for delivery about 5 minutes after the arrestAHA 2025 cardiac arrest in pregnancy algorithm |
| Calcium chloride | For hyperkalemia, calcium-channel blocker toxicity or hypermagnesemia; not routineAHA 2025 Guidelines, Part 9 (specific causes only) |
| Sodium bicarbonate | 1 mEq/kg for hyperkalemia or sodium-channel blocker toxicity; not routineAHA 2025 Guidelines, Part 9 (specific causes only) |
| Defibrillation | 2 J/kg, then 4 J/kg, then ≥4 J/kg (max 10 J/kg or the adult dose)AHA 2025 PALS cardiac arrest algorithm |
| Epinephrine IV/IO | 0.01 mg/kg (0.1 mL/kg of 0.1 mg/mL), max 1 mg, every 3–5 minutesAHA 2020 PALS algorithm; AHA 2025 PALS algorithm |
| Amiodarone IV/IO | 5 mg/kg bolus, may repeat up to 3 total dosesAHA 2020 PALS algorithm; AHA 2025 PALS algorithm |
| Lidocaine IV/IO | 1 mg/kg loading doseAHA 2020 PALS algorithm; AHA 2025 PALS algorithm |
| Epinephrine IV/IO | 0.01 mg/kg every 3–5 minutesAHA 2020 PALS bradycardia algorithm |
| Atropine IV/IO | 0.02 mg/kg, may repeat once; max single dose 0.5 mgAHA 2020 PALS bradycardia algorithm (owner to confirm the 2025 wording) |
| Adenosine IV/IO | 0.1 mg/kg rapid push (max 6 mg); second dose 0.2 mg/kg (max 12 mg)AHA 2020 PALS tachycardia algorithm |
| Synchronized cardioversion | 0.5–1 J/kg; if not effective, 2 J/kgAHA 2020 PALS tachycardia algorithm |
| Amiodarone IV/IO (wide QRS, with a pulse) | 5 mg/kg over 20–60 minutesAHA 2020 PALS tachycardia algorithm |
| Procainamide IV/IO (wide QRS, with a pulse) | 15 mg/kg over 30–60 minutesAHA 2020 PALS tachycardia algorithm |
| Fluid bolus | 10–20 mL/kg isotonic crystalloid; 5–10 mL/kg with cardiac dysfunctionAHA 2020 PALS septic shock guidance |
| Epinephrine or norepinephrine infusion | Titrated to perfusion (epinephrine 0.1–1, norepinephrine 0.05–2 mcg/kg/min)AHA 2020 PALS septic shock guidance (ranges to confirm) |
Follows the AHA 2020 Guidelines for CPR and ECC, adult algorithms (Part 3: Adult Basic and Advanced Life Support, Circulation 2020;142(suppl 2):S366–S468), with 2025 changes where confirmed.